HCAT — Health Catalyst Cashflow Statement
0.000.00%
Last trade - 00:00- $214.64m
- $270.33m
- $306.58m
- 56
- 75
- 22
- 49
Annual cashflow statement for Health Catalyst, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -115 | -153 | -137 | -118 | -69.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 75.2 | 95.1 | 72.3 | 56.5 | 43.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.83 | 4.62 | -13.9 | -13.7 | -0.66 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -26.1 | -23.1 | -35.3 | -33.1 | 14.6 |
| Capital Expenditures | -10.5 | -18.5 | -17.4 | -14.3 | -16.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | -72.1 | -121 | -21.6 | 34.6 | -6.5 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -82.6 | -140 | -39 | 20.3 | -22.9 |
| Financing Cash Flow Items | -1.62 | -6.29 | -1.34 | 0 | -2.15 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 183 | 264 | -2.61 | 2.73 | 152 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 73.9 | 101 | -76.9 | -10 | 143 |